JPMorgan Chase & Co’s Flexion Therapeutics, Inc. FLXN Stock Holding History

JPMorgan Chase & Co’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-830,546	Closed	-$5.07M	–	6178
2021 Q3	$5.07M	Buy	830,546 +96,380	+13%	+$588K	﹤0.01%	2564
2021 Q2	$6.04M	Buy	734,166 +8,012	+1%	+$65.9K	﹤0.01%	2520
2021 Q1	$6.5M	Buy	726,154 +189,553	+35%	+$1.7M	﹤0.01%	2472
2020 Q4	$6.19M	Buy	536,601 +122,814	+30%	+$1.42M	﹤0.01%	2269
2020 Q3	$4.3M	Buy	413,787 +15,121	+4%	+$157K	﹤0.01%	2318
2020 Q2	$5.24M	Buy	398,666 +223,754	+128%	+$2.94M	﹤0.01%	2121
2020 Q1	$1.38M	Buy	174,912 +26,763	+18%	+$211K	﹤0.01%	2797
2019 Q4	$3.07M	Buy	148,149 +13,976	+10%	+$289K	﹤0.01%	2463
2019 Q3	$1.84M	Buy	134,173 +6,595	+5%	+$90.4K	﹤0.01%	2782
2019 Q2	$1.5M	Sell	127,578 -7,916	-6%	-$93K	﹤0.01%	2820
2019 Q1	$1.69M	Sell	135,494 -8,785	-6%	-$110K	﹤0.01%	2736
2018 Q4	$1.63M	Sell	144,279 -8,076	-5%	-$91.4K	﹤0.01%	2767
2018 Q3	$2.85M	Buy	152,355 +9,460	+7%	+$177K	﹤0.01%	2589
2018 Q2	$3.69M	Sell	142,895 -8,502	-6%	-$220K	﹤0.01%	2438
2018 Q1	$3.39M	Sell	151,397 -14,774	-9%	-$331K	﹤0.01%	2449
2017 Q4	$4.16M	Buy	166,171 +1,771	+1%	+$44.3K	﹤0.01%	2360
2017 Q3	$3.93M	Sell	164,400 -2,950	-2%	-$70.5K	﹤0.01%	2305
2017 Q2	$3.38M	Buy	167,350 +52,763	+46%	+$1.07M	﹤0.01%	2346
2017 Q1	$3.08M	Sell	114,587 -11,235	-9%	-$302K	﹤0.01%	2379
2016 Q4	$2.39M	Buy	125,822 +6,772	+6%	+$129K	﹤0.01%	2567
2016 Q3	$2.33M	Buy	119,050 +7,075	+6%	+$138K	﹤0.01%	2385
2016 Q2	$1.68M	Sell	111,975 -6,025	-5%	-$90.2K	﹤0.01%	2536
2016 Q1	$1.09M	Buy	118,000 +4,645	+4%	+$42.8K	﹤0.01%	2651
2015 Q4	$2.18M	Buy	+113,355	New	+$2.18M	﹤0.01%	2337
2014 Q3	–	Sell	-271,676	Closed	-$3.66M	–	3529
2014 Q2	$3.66M	Sell	271,676 -56,399	-17%	-$760K	﹤0.01%	2176
2014 Q1	$5.4M	Buy	+328,075	New	+$5.4M	﹤0.01%	2005